Metabolon is excited to be exhibiting at the upcoming Advanced Technologies and Treatments for Diabetes (ATTD) meeting being held in Berlin, Germany, from February 22nd through 25th. ATTD continues to highlight innovative technologies and treatments in diabetes management and brings together developers of new technologies with the diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities and regulators, as well as people with diabetes. The ATTD community strives to discuss, exchange and discover the latest novelties and advancements, and use them to impact the lives of people with diabetes.
Join International Director of Regional Sales & Strategic Accounts, Antoine Briffaux, Business Development Director for the DACH Region, Nina Görner, and Strategic Account Manager, Robert Rankin on the exhibit floor to learn how metabolomics can contribute to immunological studies.
Booth No. 25B
